GW Erco Shimano (original) (raw)

From Wikipedia, the free encyclopedia

Italian cycling team

Cycling team

GW–Shimano–Sidermec


Team information
UCI code	GES
Registered	Italy (1996–2022)Colombia (2023–)
Founded	1996 (1996)
Discipline(s)	Road
Status	UCI ProTeam (1996–2022)UCI Continental (2023–)
Bicycles	Bottecchia
Website	Team home page
Key personnel
General manager	Gianni Savio
Team name history
19961997–19981999200020012002–2005200620072008–20092010–20112012–201420152016–201720172018–2021202220232024–	Gaseosas Glacial–Selle ItaliaKross–Selle ItaliaSelle ItaliaAguardiente Néctar–Selle ItaliaSelle Italia–PacificColombia–Selle ItaliaSelle Italia–Serramenti DiquigiovanniSerramenti PVC Diquigiovanni–Selle ItaliaSerramenti PVC Diquigiovanni–Androni GiocattoliAndroni GiocattoliAndroni Giocattoli–VenezuelaAndroni–SidermecAndroni Giocattoli–SidermecAndroni–Sidermec–BottecchiaAndroni Giocattoli–SidermecDrone Hopper–Androni GiocattoliGW–Shimano–SidermecGW Erco Shimano
GW Erco Shimano jerseyJersey
Current season

GW Erco Shimano (UCI team code: GES) is a Colombian-registered UCI Continental cycling team that participates in road bicycle racing events on the UCI Continental Circuits. Prior to 2023, the team was based in Italy and held UCI ProTeam status. Gianni Savio manages the team, with assistance from directeurs sportifs Giovanni Ellena, Antonio Castano, Didier Paindaveine and Marco Bellini.

In 2022, with the arrival of a new sponsor — Drone Hopper (an aeronautical engineering company based in Spain) — the team has received a new name Drone Hopper–Androni Giocattoli.[1]

On 5 June 2014 Patrick Facchini gave an adverse analytical finding for Tuaminoheptane and was consequently banned for 10 months.[2]

On 30 June 2015 Davide Appollonio gave an adverse analytical finding for EPO and was provisionally suspended.[3] On 27 July 2015 Fabio Taborre gave a positive test result for the banned blood-booster FG-4592 in an out-of-competition control on 16 June. The team were automatically suspended by the UCI under new rules.[4] FG-4592 (Roxadustat) is in phase 3 clinical trials and has not yet been commercialised. The drug was developed jointly by FibroGen and AstraZeneca. Unlike EPO, which directly stimulates the production of red blood cells, FG-4592 is taken orally, and stimulates natural production of EPO in a manner similar to altitude training.[5] This class of compounds has been outlawed by WADA. The UCI subsequently suspended the team for 30 days.[6]

Riders at the 2012 Route du Sud

As of 7 February 2024.[7]

| Rider Date of birth Daniel Arroyave (COL) (2000-06-19) 19 June 2000 (age 24) Lukas Blanco (COL) (2002-07-29) 29 July 2002 (age 22) Adrián Bustamante (COL) (1998-06-10) 10 June 1998 (age 26) William Colorado (COL) (2004-06-24) 24 June 2004 (age 20) Oscar Garzon (COL) (2003-06-22) 22 June 2003 (age 21) Fabian Lopez (COL) (1996-09-17) 17 September 1996 (age 28) Juan Carlos López (COL) (2001-03-25) 25 March 2001 (age 23) Andrés Mancipe (COL) (2002-07-10) 10 July 2002 (age 22) | | Rider Date of birth Alejandro Osorio (COL) (1998-05-28) 28 May 1998 (age 26) Frank Osorio (COL) (1987-08-28) 28 August 1987 (age 37) Diego Pescador (COL) (2004-12-21) 21 December 2004 (age 20) Juan Sebastian Pinilla (COL) (2004-12-08) 8 December 2004 (age 20) Edgar Pinzón (COL) (2001-05-25) 25 May 2001 (age 23) Brandon Rojas (COL) (2002-07-02) 2 July 2002 (age 22) Jeferson Ruiz (COL) (2002-07-06) 6 July 2002 (age 22) Cristian Velez (COL) (2005-02-16) 16 February 2005 (age 19) | | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |